823 related articles for article (PubMed ID: 31921562)
1. Considerations and Caveats in Combating ESKAPE Pathogens against Nosocomial Infections.
Ma YX; Wang CY; Li YY; Li J; Wan QQ; Chen JH; Tay FR; Niu LN
Adv Sci (Weinh); 2020 Jan; 7(1):1901872. PubMed ID: 31921562
[TBL] [Abstract][Full Text] [Related]
2. Navigating ESKAPE Pathogens: Considerations and Caveats for Animal Infection Models Development.
Yu H; Xu Y; Imani S; Zhao Z; Ullah S; Wang Q
ACS Infect Dis; 2024 Jun; ():. PubMed ID: 38866389
[TBL] [Abstract][Full Text] [Related]
3. Characterisation of ESKAPE Pathogens with Special Reference to Multidrug Resistance and Biofilm Production in a Nepalese Hospital.
Pandey R; Mishra SK; Shrestha A
Infect Drug Resist; 2021; 14():2201-2212. PubMed ID: 34163185
[TBL] [Abstract][Full Text] [Related]
4. Application of CRISPR-Cas system in the diagnosis and therapy of ESKAPE infections.
Qian Y; Zhou D; Li M; Zhao Y; Liu H; Yang L; Ying Z; Huang G
Front Cell Infect Microbiol; 2023; 13():1223696. PubMed ID: 37662004
[TBL] [Abstract][Full Text] [Related]
5. Antarctic Marine Bacteria as a Source of Anti-Biofilm Molecules to Combat ESKAPE Pathogens.
Artini M; Papa R; Vrenna G; Trecca M; Paris I; D'Angelo C; Tutino ML; Parrilli E; Selan L
Antibiotics (Basel); 2023 Oct; 12(10):. PubMed ID: 37887257
[TBL] [Abstract][Full Text] [Related]
6. Novel antimicrobial agents for combating antibiotic-resistant bacteria.
Chang RYK; Nang SC; Chan HK; Li J
Adv Drug Deliv Rev; 2022 Aug; 187():114378. PubMed ID: 35671882
[TBL] [Abstract][Full Text] [Related]
7. Antimicrobial Resistance in ESKAPE Pathogens.
De Oliveira DMP; Forde BM; Kidd TJ; Harris PNA; Schembri MA; Beatson SA; Paterson DL; Walker MJ
Clin Microbiol Rev; 2020 Jun; 33(3):. PubMed ID: 32404435
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of Antibiotic Resistance of ESKAPE Pathogens Over Five Years in an Infectious Diseases Hospital from South-East of Romania.
Arbune M; Gurau G; Niculet E; Iancu AV; Lupasteanu G; Fotea S; Vasile MC; Tatu AL
Infect Drug Resist; 2021; 14():2369-2378. PubMed ID: 34194233
[TBL] [Abstract][Full Text] [Related]
9. Cracking the Challenge of Antimicrobial Drug Resistance with CRISPR/Cas9, Nanotechnology and Other Strategies in ESKAPE Pathogens.
Zohra T; Numan M; Ikram A; Salman M; Khan T; Din M; Salman M; Farooq A; Amir A; Ali M
Microorganisms; 2021 Apr; 9(5):. PubMed ID: 33946643
[TBL] [Abstract][Full Text] [Related]
10. Coping with the ESKAPE pathogens: Evolving strategies, challenges and future prospects.
Aloke C; Achilonu I
Microb Pathog; 2023 Feb; 175():105963. PubMed ID: 36584930
[TBL] [Abstract][Full Text] [Related]
11. Revisiting ESKAPE Pathogens: virulence, resistance, and combating strategies focusing on quorum sensing.
Venkateswaran P; Vasudevan S; David H; Shaktivel A; Shanmugam K; Neelakantan P; Solomon AP
Front Cell Infect Microbiol; 2023; 13():1159798. PubMed ID: 37457962
[TBL] [Abstract][Full Text] [Related]
12. Going Beyond Host Defence Peptides: Horizons of Chemically Engineered Peptides for Multidrug-Resistant Bacteria.
Cavallazzi Sebold B; Li J; Ni G; Fu Q; Li H; Liu X; Wang T
BioDrugs; 2023 Sep; 37(5):607-623. PubMed ID: 37300748
[TBL] [Abstract][Full Text] [Related]
13. Emerging Strategies to Combat ESKAPE Pathogens in the Era of Antimicrobial Resistance: A Review.
Mulani MS; Kamble EE; Kumkar SN; Tawre MS; Pardesi KR
Front Microbiol; 2019; 10():539. PubMed ID: 30988669
[TBL] [Abstract][Full Text] [Related]
14. An overview of resistance profiles ESKAPE pathogens from 2010-2015 in a tertiary respiratory center in Romania.
Peneş NO; Muntean AA; Moisoiu A; Muntean MM; Chirca A; Bogdan MA; Popa MI
Rom J Morphol Embryol; 2017; 58(3):909-922. PubMed ID: 29250670
[TBL] [Abstract][Full Text] [Related]
15. Bacteriophages for ESKAPE: role in pathogenicity and measures of control.
Patil A; Banerji R; Kanojiya P; Koratkar S; Saroj S
Expert Rev Anti Infect Ther; 2021 Jul; 19(7):845-865. PubMed ID: 33261536
[TBL] [Abstract][Full Text] [Related]
16. Extent and Resistance Patterns of ESKAPE Pathogens Isolated in Pus Swabs from Hospitalized Patients.
Masoud SS; Kovacevich A; Gangji R; Nyawale H; Nyange M; Ntukula A
Can J Infect Dis Med Microbiol; 2022; 2022():3511306. PubMed ID: 36353409
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms of Antimicrobial Resistance in ESKAPE Pathogens.
Santajit S; Indrawattana N
Biomed Res Int; 2016; 2016():2475067. PubMed ID: 27274985
[TBL] [Abstract][Full Text] [Related]
18. Foodborne ESKAPE Biofilms and Antimicrobial Resistance: lessons Learned from Clinical Isolates.
Patil A; Banerji R; Kanojiya P; Saroj SD
Pathog Glob Health; 2021 Sep; 115(6):339-356. PubMed ID: 33851566
[TBL] [Abstract][Full Text] [Related]
19. Nanodelivery strategies for the treatment of multidrug-resistant bacterial infections.
Jiang L; Lin J; Taggart CC; Bengoechea JA; Scott CJ
J Interdiscip Nanomed; 2018 Sep; 3(3):111-121. PubMed ID: 30443410
[TBL] [Abstract][Full Text] [Related]
20. Antimicrobial Resistance in
Lupo A; Haenni M; Madec JY
Microbiol Spectr; 2018 Jun; 6(3):. PubMed ID: 30101740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
